Lars Schimmöller

3.2k total citations
97 papers, 1.6k citations indexed

About

Lars Schimmöller is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Lars Schimmöller has authored 97 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pulmonary and Respiratory Medicine, 47 papers in Radiology, Nuclear Medicine and Imaging and 29 papers in Rheumatology. Recurrent topics in Lars Schimmöller's work include Prostate Cancer Diagnosis and Treatment (72 papers), Prostate Cancer Treatment and Research (51 papers) and Urologic and reproductive health conditions (28 papers). Lars Schimmöller is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (72 papers), Prostate Cancer Treatment and Research (51 papers) and Urologic and reproductive health conditions (28 papers). Lars Schimmöller collaborates with scholars based in Germany, United States and Switzerland. Lars Schimmöller's co-authors include Gerald Antoch, Christian Arsov, Peter Albers, Michael Quentin, Robert Rabenalt, D. Blondin, Andreas Hiester, T. Ullrich, Erhard Godehardt and Nikolaus Becker and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Lars Schimmöller

92 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Schimmöller Germany 23 1.4k 802 489 149 90 97 1.6k
Timur H. Kuru Germany 19 1.3k 0.9× 590 0.7× 492 1.0× 171 1.1× 67 0.7× 63 1.6k
Dima Raskolnikov United States 11 1.4k 1.0× 472 0.6× 616 1.3× 225 1.5× 66 0.7× 38 1.7k
Daniel N. Costa United States 22 785 0.6× 500 0.6× 311 0.6× 166 1.1× 79 0.9× 62 1.1k
Michael Quentin Germany 23 1.1k 0.8× 830 1.0× 469 1.0× 135 0.9× 39 0.4× 63 1.5k
Robert Oldroyd United Kingdom 3 2.0k 1.5× 739 0.9× 716 1.5× 241 1.6× 135 1.5× 5 2.2k
Ahmed El‐Shater Bosaily United Kingdom 5 2.1k 1.5× 769 1.0× 749 1.5× 249 1.7× 137 1.5× 8 2.3k
Tomoaki Miyagawa Japan 14 563 0.4× 294 0.4× 253 0.5× 164 1.1× 77 0.9× 54 884
Amir H. Lebastchi United States 13 749 0.5× 228 0.3× 267 0.5× 119 0.8× 74 0.8× 33 968
Christopher S. Lim Canada 15 538 0.4× 429 0.5× 180 0.4× 118 0.8× 55 0.6× 33 892
Matthias Benndorf Germany 21 644 0.5× 752 0.9× 146 0.3× 104 0.7× 90 1.0× 70 1.3k

Countries citing papers authored by Lars Schimmöller

Since Specialization
Citations

This map shows the geographic impact of Lars Schimmöller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Schimmöller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Schimmöller more than expected).

Fields of papers citing papers by Lars Schimmöller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Schimmöller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Schimmöller. The network helps show where Lars Schimmöller may publish in the future.

Co-authorship network of co-authors of Lars Schimmöller

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Schimmöller. A scholar is included among the top collaborators of Lars Schimmöller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Schimmöller. Lars Schimmöller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ullrich, T., Matthias Boschheidgen, Tobias Franiel, et al.. (2025). Evaluation of the current status, significance, and availability of prostate MRI und MRI guided biopsy in Germany. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 197(8). 945–952.
2.
Quentin, Michael, Christian Arsov, Iréne Esposito, et al.. (2024). MRI in-bore biopsy following MRI/US fusion-guided biopsy in patients with persistent suspicion of clinically significant prostate cancer. European Journal of Radiology. 175. 111436–111436. 3 indexed citations
3.
Boschheidgen, Matthias, et al.. (2024). Value of magnetic resonance angiography before prostatic artery embolization for intervention planning. Scientific Reports. 14(1). 7758–7758. 1 indexed citations
4.
Thomas, Martin J., Matthias Boschheidgen, T. Ullrich, et al.. (2023). Multiparametric MRI characteristics of prostatitis and atrophy in the peripheral zone in men without prostate cancer. European Journal of Radiology. 169. 111151–111151. 4 indexed citations
5.
Boschheidgen, Matthias, Johannes Stegbauer, T. Ullrich, et al.. (2023). Contrast medium free selective adrenal vein sampling in the management of primary aldosteronism. Clinical Imaging. 99. 25–30. 2 indexed citations
6.
Vonend, Oliver, Mina Yakoub, András Maifeld, et al.. (2023). The Effect of Renal Denervation on T Cells in Patients with Resistant Hypertension. International Journal of Molecular Sciences. 24(3). 2493–2493. 7 indexed citations
7.
Schimmöller, Lars, Lester R. Drewes, Julian Kirchner, et al.. (2023). MRI characteristics and oncological follow-up of patients with ISUP grade group 4 or 5 prostate cancer. Abdominal Radiology. 49(1). 192–201. 3 indexed citations
8.
Boschheidgen, Matthias, T. Ullrich, Jan Philipp Radtke, et al.. (2023). Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization. CVIR Endovascular. 6(1). 9–9. 4 indexed citations
9.
Arsov, Christian, T. Ullrich, Michael Quentin, et al.. (2022). Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy. Data in Brief. 45. 108683–108683. 4 indexed citations
10.
Schimmöller, Lars, Elisabeth Weiland, Tobias Franiel, et al.. (2022). Value of T2 Mapping MRI for Prostate Cancer Detection and Classification. Journal of Magnetic Resonance Imaging. 56(2). 1 indexed citations
11.
Quentin, Michael, Lars Schimmöller, T. Ullrich, et al.. (2022). Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins. Abdominal Radiology. 47(7). 2486–2493. 19 indexed citations
12.
Boschheidgen, Matthias, Lars Schimmöller, Christian Arsov, et al.. (2021). MRI grading for the prediction of prostate cancer aggressiveness. European Radiology. 32(4). 2351–2359. 25 indexed citations
13.
Ullrich, T., D. Blondin, Christian Arsov, et al.. (2021). Impact of qualitative, semi-quantitative, and quantitative analyses of dynamic contrast-enhanced magnet resonance imaging on prostate cancer detection. PLoS ONE. 16(4). e0249532–e0249532. 8 indexed citations
14.
Schimmöller, Lars, T. Ullrich, Lino M. Sawicki, et al.. (2021). Magnetic resonance imaging improves the prediction of tumor staging in localized prostate cancer. Abdominal Radiology. 46(6). 2751–2759. 21 indexed citations
15.
Franiel, Tobias, Patrick Asbach, Dirk Beyersdorff, et al.. (2021). mpMRI of the Prostate (MR-Prostatography): Updated Recommendations of the DRG and BDR on Patient Preparation and Scanning Protocol. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 193(7). 763–777. 15 indexed citations
16.
Morawitz, Janna, Julian Kirchner, Nils Martin Bruckmann, et al.. (2021). PSMA PET/CT vs. CT alone in newly diagnosed biochemical recurrence of prostate cancer after radical prostatectomy: Comparison of detection rates and therapeutic implications. European Journal of Radiology. 136. 109556–109556. 22 indexed citations
17.
Boschheidgen, Matthias, T. Ullrich, D. Blondin, et al.. (2021). Comparison and prediction of artefact severity due to total hip replacement in 1.5 T versus 3 T MRI of the prostate. European Journal of Radiology. 144. 109949–109949. 13 indexed citations
18.
Antoch, Gerald, Johannes Stegbauer, G. Fürst, et al.. (2020). Update: Selective adrenal venous sampling (AVS) – Indication, technique, and significance. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 193(6). 658–666. 10 indexed citations
19.
Osses, Daniël F., Christian Arsov, Lars Schimmöller, et al.. (2020). Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted Biopsies. Journal of Personalized Medicine. 10(4). 270–270. 10 indexed citations
20.
Schelb, Patrick, Thomas Hielscher, Magdalena Görtz, et al.. (2020). Comparison of Prostate MRI Lesion Segmentation Agreement Between Multiple Radiologists and a Fully Automatic Deep Learning System. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 193(5). 559–573. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026